p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression

被引：0
|
作者：
Tjoe, Judy [1 ]
Brittany, Last [2 ]
Yin, Jun [2 ]
机构：
[1] Advocate Aurora Hlth, Milwaukee, WI USA
[2] Aurora Res Inst, Milwaukee, WI USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582323
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [21] Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast - Significance for breast-conserving therapy
    Goldstein, NS
    Lacerna, M
    Vicini, F
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (03) : 357 - 367
  • [22] Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy
    Han, Bing
    Du, Ye
    Fu, Ton
    Fan, Zhimin
    Xu, Shuping
    Hu, Chengxu
    Bi, Lirong
    Gao, Ting
    Zhang, Haipeng
    Xu, Weiqing
    APPLIED SPECTROSCOPY, 2017, 71 (02) : 300 - 307
  • [23] Expression of cyclin-dependent kinase inhibitor, p27 in ductal carcinoma in situ and atypical ductal hyperplasia of breast.
    Kohli, A
    Mohtasham, F
    Wuu, J
    Reale, F
    Khan, A
    LABORATORY INVESTIGATION, 1998, 78 (01) : 22A - 22A
  • [24] Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma
    Kader, Tanjina
    Hill, Prue
    Zethoven, Magnus
    Goode, David L.
    Elder, Kenneth
    Thio, Niko
    Doyle, Maria
    Semple, Timothy
    Sufyan, Wajiha
    Byrne, David J.
    Pang, Jia-Min B.
    Murugasu, Anand
    Miligy, Islam M.
    Green, Andrew R.
    Rakha, Emad A.
    Fox, Stephen B.
    Mann, G. Bruce
    Campbell, Ian G.
    Gorringe, Kylie L.
    JOURNAL OF PATHOLOGY, 2019, 248 (03): : 326 - 338
  • [25] Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer
    Mohammed, Sulma, I
    Utturkar, Sagar
    Lee, Maxwell
    Yang, Howard H.
    Cui, Zhibin
    Lanman, Nadia Atallah
    Zhang, GuangJun
    Cardona, Xavier E. Ramos
    Mittal, Suresh K.
    Miller, Margaret A.
    CANCERS, 2020, 12 (02)
  • [26] Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia:: An immunohistochemical study
    Umekita, Y
    Yoshida, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (07) : 527 - 530
  • [27] Extent and Histologic Pattern of Atypical Ductal Hyperplasia Present on Core Needle Biopsy Specimens of the Breast Can Predict Ductal Carcinoma In Situ in Subsequent Excision
    Wagoner, Michael J.
    Laronga, Christine
    Acs, Geza
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (01) : 112 - 121
  • [28] The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer
    Kang, JH
    Kim, SJ
    Noh, DY
    Choe, KJ
    Lee, ES
    Kang, HS
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (11): : 648 - 655
  • [29] The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer
    Joo Kang
    Sun Kim
    Dong-Young Noh
    Kuk Choe
    Eun Lee
    Han-Sung Kang
    Journal of Molecular Medicine, 2001, 79 : 648 - 655
  • [30] Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast
    Keohavong, P
    Gao, WM
    Mady, HH
    Kanbour-Shakir, A
    Melhem, MF
    CANCER LETTERS, 2004, 212 (01) : 121 - 130
12345